Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 10/20 | 0.73 |
| ▸ | BRAF | P15056 | 8/20 | 0.57 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.53 |
| ▸ | KDR | P35968 | 1/20 | 0.53 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.53 |
| ▸ | MAP3K8 | P41279 | 1/20 | 0.52 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8317682 | 0.92 | EGFR (0.70) | EGFRBRAFKDREPHB4MAP3K8 | |
| SCHEMBL8321437 | 0.88 | EGFR (0.80) | EGFRBRAF | |
| SCHEMBL6997201 | 0.87 | EGFR (0.71) | EGFRBRAFKDREPHB4MAP3K8 | |
| SCHEMBL8798588 | 0.84 | EGFR (1.00) | EGFRBRAF | |
| SCHEMBL8317332 | 0.84 | EGFR (1.00) | EGFR | |
| SCHEMBL6990172 | 0.84 | EGFR (0.59) | EGFRBRAFERBB2HPGDHTT | |
| SCHEMBL8312893 | 0.83 | EGFR (0.64) | EGFRERBB2HPGDHTT | |
| SCHEMBL8318038 | 0.82 | EGFR (0.77) | EGFRBRAF | |
| SCHEMBL8317451 | 0.82 | EGFR (0.69) | EGFRBRAFMAP3K8ERBB2HPGD | |
| SCHEMBL6997407 | 0.81 | EGFR (0.61) | EGFRBRAFERBB2HPGDHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0779888-B1 | PYRIMIDO [5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM | BOEHRINGER INGELHEIM PHARMA (DE) | 1999-04-28 | — | — | EP | disclosed |